Healthcare organizations gain access to Claude Opus 4.5’s reasoning capabilities specifically optimized for medical and ...

Two co-founders, Barret Zoph and Luke Metz, are heading back to OpenAI, alongside Sam Schoenholz, another former OpenAI ...

Most organisations now use AI in at least one function to complete tasks quickly, accurately, and reliably. Many positions ...

Generative AI is a type of artificial intelligence designed to create new content by learning patterns from existing data.

Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery ...

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

NVIDIA and Lilly to invest $1B in AI lab to accelerate drug discovery with BioNeMo, robotics, and large-scale biomedical ...

The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest ...